BC
APYX icon

Broadfin Capital’s Apyx Medical APYX Stock Holding History

Broadfin Capital’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-947,400
Closed -$1.85M – 89
2015
Q3 		$1.85M Hold
947,400
– – 0.1% 83
2015
Q2 		$2.64M Sell
947,400
-63,600
-6% -$175K 0.14% 86
2015
Q1 		$2.42M Buy
+1,011,000
New +$3.36M 0.19% 72

Other funds holding APYX

GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Broadfin Capital's APYX Position: Q4 2015 in Review

Broadfin Capital sold out of Apyx Medical (APYX) in Q4 2015, closing a stake of 947,400 shares — an estimated $1.85M sold.

Broadfin Capital first reported a position in APYX in Q1 2015 and held it in 3 quarters. The position peaked at $2.64M in Q2 2015. 28 funds tracked by Wall St. Rank hold APYX as of Q4 2015.

  • Broadfin Capital reported no remaining Apyx Medical position as of Q4 2015 after selling out during the quarter.
  • Broadfin Capital sold 947,400 Apyx Medical shares in Q4 2015, an estimated $1.85M.
  • Broadfin Capital first reported a position in Apyx Medical in Q1 2015 and held it in 3 quarters.
  • Broadfin Capital's Apyx Medical position peaked at $2.64M in Q2 2015.
  • 28 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2015.

Based on Broadfin Capital's 13F filing for Q4 2015, filed 16 Feb 2016.